Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | VHL |
| Variant | W117* |
| Impact List | nonsense |
| Protein Effect | loss of function - predicted |
| Gene Variant Descriptions | VHL W117* results in a premature truncation of the Vhl protein at amino acid 117 of 213 (UniProt.org). W117* has not been characterized, however, is associated with resistance to BET inhibitors in culture (PMID: 36329119) and due to the effects of other truncation mutations downstream of W117 (PMID: 14691445), is predicted to lead to a loss of Vhl protein function. |
| Associated Drug Resistance | Y |
| Category Variants Paths |
VHL mutant VHL inact mut VHL W117* |
| Transcript | NM_000551.4 |
| gDNA | chr3:g.10146523G>A |
| cDNA | c.350G>A |
| Protein | p.W117* |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_000551.4 | chr3:g.10146523G>A | c.350G>A | p.W117* | RefSeq | GRCh38/hg38 |
| NM_000551.3 | chr3:g.10146523G>A | c.350G>A | p.W117* | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| VHL W117* | leukemia | resistant | ARV-771 | Preclinical - Cell culture | Actionable | In a preclinical study, a leukemia cell line demonstrated resistance to ARV-771 and was found to have acquired VHL W117* in culture (PMID: 36329119). | 36329119 |